0.739
0.01 (1.23%)
| 前收盘价格 | 0.730 |
| 收盘价格 | 0.720 |
| 成交量 | 65,982 |
| 平均成交量 (3个月) | 95,725 |
| 市值 | 46,412,384 |
| 价格/销量 (P/S) | 1.32 |
| 股市价格/股市净资产 (P/B) | 5.65 |
| 52周波幅 | |
| 利润日期 | 13 Nov 2025 |
| 营业毛利率 | -45.59% |
| 营业利益率 (TTM) | -44.54% |
| 稀释每股收益 (EPS TTM) | -0.290 |
| 季度收入增长率 (YOY) | -2.90% |
| 总债务/股东权益 (D/E MRQ) | 185.50% |
| 流动比率 (MRQ) | 2.61 |
| 营业现金流 (OCF TTM) | -13.06 M |
| 杠杆自由现金流 (LFCF TTM) | -9.67 M |
| 资产报酬率 (ROA TTM) | -20.46% |
| 股东权益报酬率 (ROE TTM) | -96.25% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 混合的 |
| Medical Devices (全球的) | 混合的 | 混合的 | |
| 股票 | Cytosorbents Corporation | 看跌 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 1.38 |
|
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 15.29% |
| 机构持股比例 | 27.77% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Avenir Corp | 30 Sep 2025 | 5,082,838 |
| Sargent Investment Group, Llc | 30 Sep 2025 | 738,700 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 10.00 (D. Boral Capital, 1,253.18%) | 购买 |
| 中 | 5.38 (628.01%) | |
| 低 | 0.750 (HC Wainwright & Co., 1.49%) | 保留 |
| 平均值 | 5.38 (628.01%) | |
| 总计 | 1 购买, 1 保留 | |
| 平均价格@调整类型 | 0.660 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| D. Boral Capital | 14 Nov 2025 | 10.00 (1,253.18%) | 购买 | 0.660 |
| 16 Sep 2025 | 10.00 (1,253.18%) | 购买 | 0.909 | |
| HC Wainwright & Co. | 14 Nov 2025 | 0.750 (1.49%) | 保留 | 0.660 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合